-The Indian Express Government has been speaking in two tongues on intellectual property. Last week, Prime Minister Narendra Modi expressed his desire to see India adhere to “global” IP standards. The United States Trade Representative (USTR) was quick to latch on to this, noting in its latest Special 301 report: “The United States also welcomes April 2015 statements made by Prime Minister Modi recommending that India align its patent laws with international...

-The Financial Express A forensic report prepared for the Serious Fraud Investigation Office (SFIO) shows over a third of India's top 500 companies, including those in the top 100, are "managing" their accounts. It finds that companies where promoters hold more than 50% of total shareholding are more likely to take such steps to impress markets with their performance. Both domestic companies and subsidiaries of multinationals listed in India show similar trends...

-CurrentNews.in ‘Make in India' an empty slogan; Govt promotes ‘Sell in India'  The government of the USA is pushing India to revise its existing robust Intellectual Property (IP) framework that effectively protects the national and public interest by balancing the rights of IP owners with their obligation to society. Submitting to the US agenda will adversely impact innovation, production and prices, especially of medicines and medical care. Multinational pharmaceutical companies will reap...

-The Hindu Tropical diseases have often been neglected by pharmaceuticals because the size of the drug market is smaller, people have lower incomes and companies are uncertain about IPR January marked an important breakthrough in the fight against tropical diseases. Researchers and the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Delhi found a drug candidate that prevented TB and malaria pathogens from infecting human blood cells. It is not just that...

-The Telegraph New Delhi: International health activists have joined their Indian counterparts in decrying what they say are Barack Obama's dual policy on big drug companies, pledging to break their stranglehold in the US but promoting their interests in India. The activists claimed yesterday that the India-US joint statement, issued during Obama's visit to India, contains signals that the Indian government could be preparing to weaken its intellectual property regulations on medicines,...